|
|
Volumn 2, Issue 1, 2014, Pages 19-26
|
|
Role of crosslinking for agonistic CD40 monoclonal antibodies as immune therapy of cancer
|
|
Author keywords
CD40; Fc Receptor; tumor immunity
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CD40 ANTIGEN;
FC RECEPTOR;
FC RECEPTOR IIB;
IMMUNOGLOBULIN FC FRAGMENT;
MONOCLONAL ANTIBODY;
PROTEIN BINDING;
AGONISTS;
ANIMAL;
ANTIBODY SPECIFICITY;
B LYMPHOCYTE;
DISEASE MODEL;
GENETICS;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
KNOCKOUT MOUSE;
LYMPHOCYTE ACTIVATION;
METABOLISM;
MOUSE;
NEOPLASMS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIBODY SPECIFICITY;
ANTIGENS, CD40;
ANTINEOPLASTIC AGENTS;
B-LYMPHOCYTES;
DISEASE MODELS, ANIMAL;
HUMANS;
IMMUNOGLOBULIN FC FRAGMENTS;
IMMUNOTHERAPY;
LYMPHOCYTE ACTIVATION;
MICE;
MICE, KNOCKOUT;
NEOPLASMS;
PROTEIN BINDING;
RECEPTORS, IGG;
|
|
EID: 84922227732
PISSN: None
EISSN: 23266074
Source Type: Journal
DOI: 10.1158/2326-6066.CIR-13-0152 Document Type: Article |
|
Times cited : (75)
|
|
References (0)
|